[Federal Register Volume 69, Number 212 (Wednesday, November 3, 2004)]
[Notices]
[Pages 64062-64067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24514]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


State Implementation Projects for Preventing Secondary Conditions 
and Promoting the Health of People With Disabilities

    Announcement Type: New.
    Funding Opportunity Number: RFA 05007.
    Catalog of Federal Domestic Assistance Number: 93.184.
    Key Dates: Letter of Intent Deadline (LOI): December 3, 2004.
    Application Deadline: January 3, 2005.
    Executive Summary: The State capacity cooperative agreements are 
providing financial assistance to: (1) Establish and/or sustain State 
offices for preventing secondary conditions and promoting the health of 
people with disabilities as a State public health priority, and serve 
as a technical assistance (TA) resource and statewide focus for the 
prevention of secondary conditions; (2) support an advisory function to 
coordinate and provide policy and program direction guidance in the 
State; (3) develop and/or implement a State strategic plan or policy 
instrument for health promotion for persons with disabilities; (4) 
establish and implement partnerships with universities or state health 
departments or other state agencies to support and complement project 
activities; (5) maintain and refine prescribed public health 
surveillance or survey activities related to disability and/or 
secondary conditions in order to implement prevention efforts and 
program evaluation activities; (6) provide TA to communities; and (7) 
promote education and health promotion programs for persons with 
disabilities, conduct training of health professionals, and facilitate 
access to services for persons with disabilities.

I. Funding Opportunity Description

    Authority: This program is authorized under Sections 311, 
317(k)(2), and 317C of the Public Health Service Act, (42 U.S.C. 
243, 247b(k)(2), and 247b-4) as amended.

    Purpose: The Centers for Disease Control and Prevention (CDC) 
announces the availability of fiscal year (FY) 2005 funds for 
cooperative agreements for State implementation projects for preventing 
secondary conditions and promoting the health of persons with 
disabilities. This program addresses the ``Healthy People 2010'' focus 
area(s) of Disability and Secondary Conditions.
    The purpose of this program is to support States in preventing 
secondary conditions in persons with disabilities and in implementing 
effective health promotion and wellness programs for persons with 
disabilities. This announcement is comprised of two levels of 
cooperative agreements:

Level II--State Implementation Projects
Level III--State Infrastructure Development Projects

    Measurable outcomes of the program will be in alignment with one 
(or more) of the following performance goal(s) for the National Center 
on Birth Defects and Developmental Disabilities: Improve the health and 
quality of life of Americans with disabilities.
    Activities: Activities for Levels II and III: Note that items (a) 
through (e) relate to activities for both Level II and III State 
applicants. Items (f) and (g) below relate only to Level II State 
applicants.
    (a) Establish the organizational location and focus for the project 
within the applicant agency and engage key collaborators (e.g., 
disability service organizations, advocacy groups, universities) in the 
design and attainment of program goals and objectives.
    (b) Expand or develop an advisory function comprised of key 
partners representing the disability community. The advisory group will 
contribute to the policy and planning functions of the applicant. At 
least 30 percent of the advisory membership must have a disabling 
condition.
    (c) Collect and analyze data using survey questions in the 
Behavioral Risk Factor Surveillance System (BRFSS) or other survey 
instruments.
    (d) Investigate and document the process (to be or already) 
established of gaining access to or obtaining information from 
administrative data within the State to plan and implement activities 
to prevent secondary conditions and improve the health of people with 
disabilities to which the data relate.
    (e) Disseminate health promotion information through diverse and 
innovative marketing plans.
    (f) Plan, implement and evaluate over the project period health 
promotion interventions related to Chapter 6 objectives in Healthy 
People 2010 or the leading health indicators for people with 
disabilities.
    (g) Promote and help develop strategic planning instruments that 
will influence State-level public health and health promotion 
activities such as Healthy People 2010 objectives.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    <bullet> Provide scientific and programmatic TA as requested or 
indicated in the planning and conduct of disability data collection, 
communications, and health promotion activities.
    <bullet> Provide a point of referral and coordination for State, 
regional and/or national data pertinent to the disabling process.

[[Page 64063]]

    <bullet> Provide assistance to States in regard to BRFSS, or other 
survey-based sources of data.
    <bullet> Facilitate coordination with other federal statistical 
research and data resources.
    <bullet> Assist State projects in their development of program 
evaluation measures and processes.

II. Award Information

    Type of Award: Cooperative Agreement. CDC involvement in this 
program is listed in the Activities Section above.
    Fiscal Year Funds: 2005.
    Approximate Total Funding: $2,500,000. (This amount is an estimate, 
and is subject to availability of funds.)
    Approximate Number of Awards: 9-11.
    Approximate Average Award: $280,000 for Level II; $125,000 for 
Level III. (These amounts are for the first 12-month budget period, and 
includes both direct and indirect costs.)
    Floor of Award Range: $175,000 for Level II; $125,000 for Level 
III.
    Ceiling of Award Range: $360,000 for Level II; $150,000 for Level 
III.
    Anticipated Award Date: April 1, 2005.
    Budget Period Length: 12 months.
    Project Period Length: Two years.
    Level II: CDC anticipates making up to 7 awards for projects which 
will be designated as Level II states. Funding constraints dictate that 
no more than one of the eligible states will receive an award at the 
$360,000 level. The average award for remaining states eligible as a 
Level II applicant will be $280,000. Requests for Level II awards in 
excess of $360,000 will be considered as non-responsive and will be 
returned to the applicant. The major criteria for Level II awards will 
be that intervention programs for persons with disabilities are 
established and being implemented within the agency jurisdiction and 
constituency served.
    Level III: CDC anticipates making up to 4 awards for projects which 
will be designated as Level III states. It is expected that Level III 
awards will average $125,000 with no award to be made in excess of 
$150,000. Requests for Level III awards in excess of $150,000 will be 
considered as non-responsive and will be returned to the applicant. 
Funding for Level III projects is designed to develop State 
infrastructure, and short-term implementation of intervention 
activities is not required.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible Applicants

    Assistance will be provided to the health departments of States or 
their bona fide agents or designees, including the District of 
Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the 
Commonwealth of the Northern Mariana Islands, American Samoa, Guam, 
federally recognized Indian tribal governments, the Federated States of 
Micronesia, the Republic of the Marshall Islands, and the Republic of 
Palau.
    Eligibility is also extended to agencies and organizations other 
than the official health department. In those cases, these entities 
must provide written concurrence from that health agency and describe 
the proposed collaborative relationship. Under that circumstance, the 
role of the official State health agency must be shown to be 
complementary, collaborative, and demonstrate clearly defined 
programmatic commitments and obligations.
    Only one application from each State or Territory may be submitted. 
The agency determined to be the applicant for the State may apply for 
more than one Level (i.e. Level II or Level III) of funding under the 
eligibility requirements for each. Once that agency is determined, no 
other agency within that State can submit an application for any other 
Level of funding. However, a complete and separate application must be 
submitted from that same applicant agency/entity based on the program 
requirements and evaluation criteria for that component (Level) of this 
announcement. Only one award will be issued per State.
    States are considered the most appropriate applicants since the 
national goals of this program include developing capacity in all 
States and their delivery systems to monitor, characterize, and improve 
the health of people with disabilities and prevent secondary 
conditions.
    Two levels of cooperative agreements will be awarded:
    Level II: Eligible applicants for Level II funding are States 
currently funded under CDC PA 02007, State Implementation Projects for 
Preventing Secondary Conditions and Promoting the Health of People with 
Disabilities. Eligible states include Arkansas, California, Illinois, 
Massachusetts, Montana, New Jersey, Oregon, Rhode Island, Vermont, and 
Virginia. In addition, eligible applicants include the District of 
Columbia, all States, federally recognized Indian Tribes and United 
States Territories.
    To be eligible, applicants for Level II must also provide:
    (a) The State Plan for Disability and Health. The Plan can be in 
final form or in the process of final review.
    (b) An established and functioning disability and health advisory 
component of which at least 30 percent of the members are people with 
disabilities. The advisory group contributes to the policy and planning 
functions of the applicant. A listing of the advisory committee 
membership with their areas of expertise and interest is to be provided 
and certified by the committee/council chairperson, with an indication 
only as to the number of persons with disabilities within that group.
    A copy of the State Plan and the composition and function statement 
of the Advisory Council must be provided as attachments to the 
application.
    Level III: Eligible applicants for Level III funding are the 
District of Columbia, all States, federally recognized Indian Tribes 
and United States Territories regardless of their current CDC 
Disability and Health Program funding status.
    CDC will conduct a conference call November 16, 2004 with 
prospective applicants to answer questions regarding this announcement. 
If you wish to participate, contact by e-mail the official noted for 
Program TA in the ``Agency Contacts'' section of this announcement 
(<a href="/cdn-cgi/l/email-protection#baded8dfcecec9fad9ded994ddd5cc"><span class="__cf_email__" data-cfemail="35515750414146755651561b525a43">[email protected]</span></a>). You will be informed by return e-mail as to the time, 
telephone number, and passcode for that call. You are encouraged to 
provide advance questions that will be part of the general discussion 
during the call.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    If you request a funding amount greater than the ceiling of the 
award range, your application will be considered non-responsive, and 
will not be entered into the review process. You will be notified that 
your application did not meet the submission requirements.
    Special Requirements:
    If your application is incomplete or non-responsive to the special 
requirements listed in this section, it will not be entered into the 
review

[[Page 64064]]

process. You will be notified that your application did not meet 
submission requirements.
    <bullet> Late applications will be considered non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
    <bullet> Note: Title 2 of the United States Code Section 1611 
states that an organization described in Section 501(c)(3) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161. Application forms and instructions are available on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIMS) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Letter of Intent (LOI): A non-binding letter of intent is requested 
from prospective applicants. The letter should not exceed one page. It 
should identify the announcement number, the proposed project director, 
and denote whether funding Level II or III is being proposed. This 
letter will allow CDC to determine the amount of interest in the 
announcement, to plan the review more efficiently, and to ensure that 
each applicant receives timely and relevant information prior to the 
application submission date. Your LOI must be written in the following 
format:

<bullet> Maximum number of pages: One
<bullet> Font size: 12-point unreduced
<bullet> Single spaced
<bullet> Paper size: 8.5 by 11 inches
<bullet> Page margin size: One inch
<bullet> Printed only on one side of page
<bullet> Written in plain language, avoid jargon

    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:

<bullet> Maximum number of pages: 35 pages if applying for Level II; 25 
pages if applying for Level III. If your narrative exceeds the page 
limit, only the first pages which are within the page limit will be 
reviewed.
<bullet> Font size: 12-14 point unreduced
<bullet> Double spaced
<bullet> Paper size: 8.5 by 11 inches
<bullet> Page margin size: One inch
<bullet> Printed only on one side of page
<bullet> Held together only by rubber bands or metal clips; not bound 
in any other way
<bullet> Attachments to the application should be held to a minimum in 
keeping to those items referenced or required by this Announcement. The 
attachments do not count toward the page application limit for that 
funding level

    Your narrative should address activities to be conducted over the 
entire project period. Level II and Level III applicants must include 
the following items in the order listed:
    1. Background and Need:
    a. Describe the current status of disability and health programs in 
the state, and describe your understanding of the need for this program 
in the state. Identify the extent of the problem, available services 
and support resources, at-risk groups, knowledge gaps, and the use of 
this award in meeting such needs. Provide the data sources that 
document the need for the program.
    b. Provide justification for emphasizing select populations or the 
sub-group of disabling conditions to be targeted by the applicant. 
Provide references for any studies or sources from which this 
information was obtained.
    2. Collaborations:
    a. Discuss the collaborations proposed with principal partners in 
the conduct of the project, such as a formal university or state agency 
alliance that will have an impact on the capacity of the State to mount 
or improve efforts in health promotion and the prevention of secondary 
conditions. Provide letters of support describing the nature of each 
collaboration, and the extent of the collaborative commitment in the 
scope of work and human and financial resources.
    b. Describe progress in developing or implementing a formal State 
Plan for the prevention of secondary conditions and promoting the 
health of people with disabilities, and describe the role of a new or 
existing advisory function to aid in that effort and in other assigned 
responsibilities.
    3. Epidemiologic Capacity:
    a. Furnish descriptions of the epidemiologic capacity structure in 
place or proposed to coordinate and promote data collection and 
analysis including the BRFSS, other state data sources, selected 
administrative data sets, and those in conjunction with identified 
partners.
    b. Describe how the university or state agency partnership or 
collaboration with the state BRFSS Coordinator or other agencies has or 
will be engaged to facilitate epidemiologic excellence. Provide data 
from the BRFSS, other state sources, or selected administrative data 
describing both the magnitude of disability, and the risk and 
protective factors related to the onset and progress of secondary 
conditions.
    c. Describe how data will, or is being used, for policy development 
and planning.
    4. Program Work Plan:
    a. Provide measurable and time-phased goals and objectives for the 
project period. Objectives should be outcome oriented as much as 
possible, rather than focusing on processes or outputs. Provide 
baselines for each objective. The work plan should include the goal of 
defining the burden of disabilities.
    b. Describe proposed activities that will lead to the achievement 
of the stated goals and objectives. Activities may include the 
following:

<bullet> Conducting the BRFSS survey and analyzing the data
<bullet> Initiating or expanding strategic partnerships with specific 
activities identified
<bullet> Providing TA to communities
<bullet> Promoting education and health promotion programs for persons 
with disabilities
<bullet> Conducting training of health professionals
<bullet> Facilitating access to services for persons with disabilities

    5. Evaluation Plan: Discuss how the project will measure the 
outcomes of proposed targeted activities (e.g., increases in public 
awareness, knowledge, behavior, and the overall benefits of State 
Planning and advisory activities). Include a description of the 
evaluation design, methods, partners, and processes to be followed for 
conducting program evaluation.
    6. Management/Staffing Plan:
    a. Provide a description of the proposed staffing for the project, 
and the plan to expedite filling of all positions. The plan must 
include the appointment of a full time program manager/coordinator.
    b. Discuss the responsibilities of individual staff members 
including the level of effort and time allocation for each project 
objective by staff position.
    c. Describe plans for on-going management and operation of the 
project in the event of unexpected vacancies, hiring restrictions, or 
difficulty in recruiting for key positions.

[[Page 64065]]

    d. Describe how the integration of disability and health functions 
as an integral component of applicant/health agency services and 
operations will be achieved.
    e. Present a graphic flowchart (i.e., Gantt chart) denoting time 
interval performance expectations over the first budget year.
    7. Budget and Narrative Justification: Provide a detailed line-item 
budget and narrative justification for all operating expenses 
consistent with and clearly related to the proposed objectives and 
planned activities.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes:

<bullet> Curriculum Vitaes
<bullet> Resumes
<bullet> Organizational Charts
<bullet> Letters of Support
<bullet> Graphic workplans
<bullet> State plans for disability and health (Level II only)
<bullet> Listing of Advisory Committee membership (Level II only)

    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm. If your application form does not have a 
DUNS number field, please write your DUNS number at the top of the 
first page of your application, and/or include your DUNS number in your 
application cover letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    LOI Deadline Date: December 3, 2004.
    CDC requests that you send an LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, the LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review.
    Application Deadline Date: January 3, 2005.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you submit your application by the United States Postal 
Service or commercial delivery service, you must ensure that the 
carrier will be able to guarantee delivery by the closing date and 
time. If CDC receives your submission after closing due to: (1) Carrier 
error, when the carrier accepted the package with a guarantee for 
delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the submission as having 
been received by the deadline.
    This announcement is the definitive guide on LOI and application 
content, submission address, and deadline. It supersedes information 
provided in the application instructions. If your submission does not 
meet the deadline above, it will not be eligible for review, and will 
be discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your submission. If you 
have a question about the receipt of your LOI or application, first 
contact your courier. If you still have a question, contact the PGO-
TIMS staff at: 770-488-2700. Before calling, please wait two to three 
days after the submission deadline. This will allow time for 
submissions to be processed and logged.

IV.4. Intergovernmental Review of Applications

    Your application is subject to Intergovernmental Review of Federal 
Programs, as governed by Executive Order (EO) 12372. This order sets up 
a system for state and local governmental review of proposed federal 
assistance applications. You should contact your state single point of 
contact (SPOC) as early as possible to alert the SPOC to prospective 
applications, and to receive instructions on your state's process. 
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
    <bullet> Reimbursement of pre-award costs is not allowed.
    <bullet> Funds may not be used for construction.
    <bullet> Funds may not be used to supplant State, local, or other 
applicant funds for the purpose of this cooperative agreement.
    <bullet> Funds may not be used to lease or purchase space or 
facilities.
    <bullet> Funds may not be used for patient care.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm.

IV.6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or e-mail to: Donald Betts, CDC, NCBDDD, 1600 Clifton 
Road, MS E 88, Atlanta, GA 30333, 404-498-3957, 404-498-3060, 
<a href="/cdn-cgi/l/email-protection#3d595f5849494e7d5e595e135a524b"><span class="__cf_email__" data-cfemail="54303631202027143730377a333b22">[email protected]</span></a>.
    Application Submission Address: Submit the original and two hard 
copies of your application by mail or express delivery service to: 
Technical Information Management Section, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    Level II and Level III applicants will be evaluated individually 
against the following criteria by an independent review group appointed 
by CDC:
1. Program Work Plan: (20 Points)
    a. The extent to which the formal work plan includes a clear and 
concise presentation of project goals and objectives which are 
specific, measurable, achievable, and time-referenced.
    b. The extent to which the applicant effectively documents its plan 
to provide TA, education and training, and health promotion programs.
    c. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in proposed research. This includes:
    (1) The proposed justification when representation is limited or 
absent;
    (2) A statement as to whether the design of the study is adequate 
to measure differences when warranted; and
    (3) A statement as to whether the plans for recruitment and 
outreach for

[[Page 64066]]

study participants include the process of establishing partnerships 
with community(ies) and recognition of mutual benefits.
2. Evidence of Collaboration: (20 Points)
    a. The extent to which the proposed collaborations are well 
documented with letters of commitment conveying specific indications as 
to the level of involvement and material effort to be provided in 
support of project objectives.
    b. The extent to which the applicant adequately describes the 
proposed or existing advisory function, including evidence of 
representation of persons with disabilities and their role and capacity 
to influence State-level policy.
    c. The extent to which the applicant presents evidence of strong 
partnerships between the state health department, universities, and 
community-based organizations, and describes how these collaborations 
will result in successful infrastructure development.
    d. The extent to which the proposed approach demonstrates an 
effective process to develop and publish a State strategic plan with a 
Healthy People 2010 emphasis, and/or policy directive for the 
prevention of secondary conditions as a precursor to the development of 
the State Plan.
3. Epidemiologic Capacity: (20 Points)
    a. The extent to which the application conveys the epidemiologic 
capacity and structure in place to coordinate and facilitate 
disability-related data collection, analysis, interpretation, and 
dissemination.
    b. The extent to which the applicant adequately describes how it 
will conduct the BRFSS, access other State disability information 
sources related to the population of interest such as administrative 
data sets; and how such data is currently, or will be utilized.
4. Program Evaluation: (20 Points)
    a. The extent to which the applicant presents an appropriate and 
viable plan for the overall evaluation of the project; including the 
design, methods (quantitative methods as well as qualitative approaches 
such as focus groups), partners, and processes to be followed for 
conducting project evaluation.
    b. The extent to which the applicant adequately outlines the 
methods and process by which it will self-evaluate its performance 
towards meeting all specified time-phased objectives.
5. Evidence of Need and Understanding of the Problem: (10 Points)
    a. The extent to which the applicant provides an adequate 
description and understanding of the magnitude of disabilities showing 
evidence (as available) of estimates of prevalence, demographic 
indicators, severity, effect on families and caregivers, and associated 
costs.
    b. The degree to which the applicant provides a suitable 
description of the extent of current activities related to disability 
and health, including those addressing the prevention of secondary 
conditions within the State.
6. Management/Staffing Plan: (10 Points)
    a. The extent to which the applicant provides adequate descriptions 
of key staff responsibilities addressing proposed major activities.
    b. The extent to which the organizational placement of the project 
assures optimal visibility and influence based on evidence provided by 
applicant agency leadership.
    c. The extent to which the applicant addresses how it will assure 
and achieve integration of disability and health functions as an 
integral component of applicant/health agency services and operations.
7. Budget Justification: (Not Scored)
    The extent to which the proposed budget is reasonable, related to 
the proposed objectives and activities.
8. Human Subjects if Applicable: (Not Scored)
    The extent to which the applicant complies with the Department of 
Health and Human Services Regulations (45 CFR Part 46) regarding the 
protection of human subjects.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by the National 
Center on Birth Defects and Developmental Disabilities (NCBDDD). 
Incomplete applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel appointed by CDC will evaluate complete 
and responsive applications according to the criteria listed in the 
``V.1. Criteria'' section above. Members of the objective review panel 
will be appointed in accordance with Department of Health and Human 
Services policy.
    Applications will be funded in order by score and rank determined 
by the review panel. In addition, the following factors may affect the 
funding decission: maintaining geographic diversity, and preference to 
applicants funded in a previous project period.
    CDC will provide justification for any decision to fund out of rank 
order.

V.3. Anticipated Announcement and Award Dates

    It is anticipated that awards will be announced on March 15, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Parts 74 and 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

<bullet> AR-1 Human Subjects Requirements.
<bullet> AR-2 Requirement for Inclusion of Women and Racial Minorities 
in Research.
<bullet> AR-7 Executive Order 12372.
<bullet> AR-9 Paperwork Reduction Act Requirements.
<bullet> AR-10 Smoke-Free Workplace Requirements.
<bullet> AR-11 Healthy People 2010.
<bullet> AR-12 Lobbying Restrictions.
<bullet> AR-22 Research Integrity.

    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no less than 90 days before the end 
of the budget period. The progress report will

[[Page 64067]]

serve as your non-competing continuation application, and must contain 
the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Budget.
    e. Measures of Effectiveness.
    f. Additional Requested Information.
    2. Financial status report no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement.
    For general questions, contact: Technical Information Management 
Section, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341, Telephone: 770-488-2700.
    For program TA, contact: Donald Betts, Lead Public Health Analyst, 
CDC, NCBDDD, 1600 Clifton Road, NE (MS E 88), Telephone: 404-498-3957, 
E-mail: <a href="/cdn-cgi/l/email-protection#d5b1b7b0a1a1a695b6b1b6fbb2baa3"><span class="__cf_email__" data-cfemail="e5818780919196a5868186cb828a93">[email protected]</span></a>.
    For financial, grants management, or budget assistance, contact:
    Gary Teague, Grants Management Specialist, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-
488-1981, E-mail: <a href="/cdn-cgi/l/email-protection#397e6d5c585e4c5c795a5d5a175e564f"><span class="__cf_email__" data-cfemail="1a5d4e7f7b7d6f7f5a797e79347d756c">[email protected]</span></a>.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC Web site, Internet address: http://www.cdc.gov. Click on 
``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: October 28, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-24514 Filed 11-2-04; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>